Emily Shutman

Emily Shutman is a Biotech Equity Research Associate at Leerink Partners since November 2022, specializing in targeted oncology. Prior experience includes serving as a Senior Analyst and Analyst at ClearView Healthcare Partners from June 2020 to October 2022. Emily has interned at Pfizer as a Global Supply Intern, where responsibilities included portfolio optimization and supply chain metric tracking. Previous internships include conducting research at Nemours and The Feinstein Institute, as well as a research assistant role at Stony Brook University analyzing trace metals' effects on algae health. Emily holds a Bachelor's degree in Molecular Biology from Haverford College, completed in 2020.